'Pharma Bro' Martin Shkreli Arrested on Securities Fraud Charges The CEO of Turing Pharmaceuticals became infamous earlier this year when he drastically raised the price of a drug taken by AIDS patients.

By Geoffrey Smith

This story originally appeared on Fortune Magazine

Getty Images
Martin Shkreli, the now-notorious CEO of Turing Pharmaceuticals.

Martin Shkreli, the now-notorious CEO of Turing Pharmaceuticals, has been arrested on suspicion of securities fraud, according to Bloomberg News.

Shkreli, 32, became infamous earlier this year when he drastically raised the price of a drug taken by AIDS patients, but Bloomberg said the case against him is unrelated to that.

Instead, prosecutors have charged him with illegally taking stock from Retrophin Inc., a biotech firm which he founded in 2011, and using it to pay off unrelated business debts, Bloomberg said.

Shkreli's hedge fund MSMB Capital Management suffered heavy losses as a result of the fraud, the agency added, referring also to allegations of "secret payoffs" and "sham consulting arrangements."

News Editor for Europe at Fortune.com.

Want to be an BIZ Experiences Leadership Network contributor? Apply now to join.

Leadership

Lead From the Top: 5 Core Responsibilities of a CEO

Knowing exactly what the chief executive's role entails is critical for steering a company to success.

Business Solutions

Tell Your Story and Share Your Strategies with the $49 Youbooks Tool

Use AI to craft full-length non-fiction books that can help build your brand.

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for BIZ Experiencess to pursue in 2025.

Science & Technology

OpenAI's Latest Move Is a Game Changer — Here's How Smart Solopreneurs Are Turning It Into Profit

OpenAI's latest AI tool acts like a full-time assistant, helping solopreneurs save time, find leads and grow their business without hiring.

Starting a Business

I Built a $20 Million Company by Age 22 While Still in College. Here's How I Did It and What I Learned Along the Way.

Wealth-building in your early twenties isn't about playing it safe; it's about exploiting the one time in life when having nothing to lose gives you everything to gain.

Science & Technology

AI Isn't Plug-and-Play — You Need a Strategy. Here's Your Guide to Building One.

Don't just "add AI" — build a strategy. This guide helps founders avoid common pitfalls and create a step-by-step roadmap to harness real value from AI.